微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 13.52% | 222.67% | 901.48% | 2/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.35% | 5.47% | -87.58% | 62/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 10.87% | 31.6% | 47.09% | 20/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 7.39% | 2.92% | 76.37% | 28/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.19% | 16.71% | 227.34% | 39/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.28% | 0% | -84.5% | 62/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 8.26% | 63.56% | 15.04% | 41/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 7.18% | 59.91% | 100% | 41/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.59% | 48.96% | 180.47% | 56/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.28% | -57.62% | -74.65% | 68/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 5.05% | -96.55% | 12.47% | 72/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.49% | -96.81% | 86.31% | 71/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.41% | -98.31% | -20.2% | 74/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.02% | -97.88% | -97.94% | 44/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 146.56% | 333.35% | 3.99% | 1/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 140.94% | 5606.07% | -0.92% | 1/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 142.25% | 61947.82% | -0.32% | 1/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 142.71% | 7035.5% | 321.97% | 1/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 33.82% | 142.26% | 1269.23% | 15/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 2.47% | -87.46% | 1173.91% | 102/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | -0.23% | -101.62% | -111.5% | 115/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2% | -26.47% | -85.67% | 74/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 13.96% | 193.44% | -29.1% | 72/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 19.69% | 476.48% | 38.27% | 28/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 14.24% | 516.37% | 423.53% | 31/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.72% | 216.24% | 118.21% | 31/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -14.94% | -59.79% | -185.66% | 116/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | -5.23% | -14.44% | -52.92% | 65/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | -3.42% | 15.76% | -46.15% | 73/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | -2.34% | -25.81% | 74.97% | 56/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | -9.35% | 24.17% | -104.6% | 106/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | -4.57% | 22.67% | -12.56% | 54/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | -4.06% | -26.88% | -118.28% | 58/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | -1.86% | -78.85% | 84.91% | 52/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | -12.33% | 9% | -108.63% | 102/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | -5.91% | 48.16% | -84.69% | 48/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | -3.2% | 61.07% | -207.69% | 56/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | -1.04% | 56.49% | 92.32% | 44/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | -13.55% | 40.18% | -18.86% | 78/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | -11.4% | -24.18% | -38.69% | 39/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | -8.22% | -71.97% | -243.93% | 49/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | -2.39% | -6.22% | 89.45% | 34/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |